After humans left Chernobyl, animals stayed behind. Radiation seeped into every cell, damaging DNA and altering how bodies developed. Some animals were born with deformities, tumors, or shortened ...
Rucaparib received FDA approval for BRCA-mutated mCRPC after prior androgen receptor–directed therapy, based on the TRITON3 trial results. The trial demonstrated significant improvement in ...
Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options. Dr. Girindra Raval sat down for an interview ...
A new influenza strain spreading internationally could bring an early flu season to California, according to health experts. They said the strain, with the full name H3N2 subclade K, is a mismatch for ...
Flu season is here, and while flu activity remains low around the country, it's increasing and typically spikes after holiday gatherings. Thakur Jilleni visited his local Walgreens to get his annual ...
A mutated version of the flu is causing a wave of infections around the world. Known as subclade K, it may evade the current flu vaccine. Infectious disease doctors say we may be in for a bad flu ...
A new mutated strain of the common flu, influenza H3N2, subclade K, is spreading across the Northern Hemisphere, including the United States. This particular strain has gained dominance in many ...
Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor type in patients with non-small cell lung cancer (NSCLC), the FDA has given ...
Health officials in Illinois are warning of a new and unexpected mutation that could make for a "more serious flu season" as cases are already on the rise. The new variant, known as "Subclade K," is ...
The FDA has approved ziftomenib (Komzifti, Kura Oncology) for adults with relapsed or refractory (R/R) acute myeloid leukemia (AML) harboring a nucleophosmin 1 (NPM1) mutation, which occurs in up to ...
What Is Ziftomenib, and Why Does It Matter? Ziftomenib, sold under the brand name Komzifti, is a new oral medicine approved to treat adults with a type of blood cancer called acute myeloid leukemia ...